Overcome the challenges of PMS2 variant calling with Devyser LynchFAP – our new NGS solution
Devyser LynchFAP is the latest addition to Devyser’s expanding hereditary cancer screening...
Event I October 20-24, 2023
ESMO Congress 2023 in Madrid, Spain
We are very excited to be a part of the ESMO Congress and looking forward to meeting you. Come and meet the Devyser team in booth #706 to learn about our products.
Are you interested in hereditary cancer genetic testing?
Register for the webinar to learn how the newly launched Devyser LynchFAP targeted NGS solution overcomes PMS2 gene variant calling challenges
Featured solutions
Devyser launches two new genetic testing solutions for hereditary cancer
Devyser is thrilled to announce the launch of two new products, Devyser LynchFAP and Devyser BRCA...
Simplify your lab workflow with single-tube NGS library preparation method
As a lab manager, you know the importance of streamlining workflows to maximize productivity and...
NGS identification of both male and female cancer risks
Do you know a man who has participated at least once in “Movember”? Every year, thousands of men...